Lynne Matallana has been invited to be a co-chair at a key National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), Division of Translational Research workshop entitled: Developing Meaningful Endpoints for Pain Clinical Trials. The event which was to take place in March 2020 is now scheduled to be held later in the year.
The goal of the workshop is to identify novel approaches to clinical trial outcome measures for pain. Over the course of two-day workshop, the participants will review the current state of the pain therapeutics development pathway from government, industry, and academic perspectives.
Breakout panel discussion sessions will be used to debate the development of non-disease specific pain outcome measures and the use of biomarkers and surrogate endpoints as they relate to acute pain, chronic pain, and the acute to chronic transition.
The sessions will also discuss challenges and opportunities to develop, validate, and implement such outcomes measures. These discussions will be used to prepare concrete recommendations that can be implemented in clinical trials of therapeutics across pain conditions to move the field forward.
The workshop will include a broad representation of leading experts from academic, biopharmaceutical industry and government. Lynne will be representing the patients perspective and will speak directly to the needs and interests of people with fibromyalgia and other chronic pain illnesses.
